Tissue Regenix signs 10-year lease on facility in US to ramp up processing capacity


Medical devices group Tissue Regenix signed a 10-year lease agreement on a facility to expand processing capacity at its manufacturing base in San Antonio, Texas. The agreement also included the option to purchase the facility at a later date.

The company said that it had plans to build further processing and packaging clean rooms in the new facility, increasing the company's ability to process more tissue and produce products.

'The new facility underpins the company's strategy of building strategic partnerships, accelerating US market penetration and pursuing geographic expansion opportunities,' the company said.

At 8:46am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 3.85p

Related content

Tissue Regenix appoints CFO

Medical devices company Tissue Regenix has appointed David Cocke as CFO and director to the board with immediate effect.

Mr Cocke has over 29...

Thu, 21/01/2021 - 08:24

Tissue Regenix makes first porcine tendon deliveries

Regenerative medical devices company Tissue Regenix said it had notched first deliveries of its porcine tendon product, with additional shipments expected in early 2021.


Wed, 02/12/2020 - 07:39

Tissue Regenix appoints Daniel Lee as CEO

Regenerative medical devices company Tissue Regenix said it had appointed Daniel Lee as chief executive.

Lee was currently the head of the company's US operations,...

Tue, 17/11/2020 - 08:50

Tissue Regenix losses narrow on cost cutting

Regenerative medical devices company Tissue Regenix posted a narrower first-half loss after it cut overheads.

Pre-tax losses for the six months through June amounted to...

Wed, 02/09/2020 - 07:47

Tissue Regenix enters UK distribution agreement for porcine tendon product

Regenerative medical devices company Tissue Regenix said it had entered into a distribution agreement and secured its first order with a speciality supplier of orthopaedic...

Mon, 24/08/2020 - 07:50